| Literature DB >> 4052413 |
K S Roth, P D Spencer, E S Higgins, R F Spencer.
Abstract
Succinylacetone, a catabolic end-product of tyrosine, is excreted in large quantities in urine from individuals with hereditary tyrosinemia and the Fanconi syndrome. Succinylacetone inhibits rat renal tubular concentrative uptake of the glucose transport analogue, methyl alpha-D-glucoside, in a noncompetitive and reversible fashion. This compound also depresses oxygen consumption by the rat renal tubule without fine structural damage to mitochondria. It is concluded that succinylacetone may be a useful probe in elucidation of the biochemical mechanism underlying the human Fanconi syndrome.Entities:
Mesh:
Substances:
Year: 1985 PMID: 4052413 DOI: 10.1016/0005-2736(85)90225-1
Source DB: PubMed Journal: Biochim Biophys Acta ISSN: 0006-3002